12 Best Healthcare Stocks Under $50 to Invest In

Page 4 of 11

8. Royalty Pharma Plc (NASDAQ:RPRX)

Number of Hedge Fund Holders: 34

Royalty Pharma Plc (NASDAQ:RPRX) is one of the best healthcare stocks under $50 to invest in. On January 30, Royalty Pharma Plc (NASDAQ:RPRX) was upgraded to Buy from Neutral by UBS, with the firm raising the price target on the stock to $49 from $38. The firm told investors that Royalty Pharma Plc (NASDAQ:RPRX) has delivered a series of attractive royalty deals, “meaningfully” bolstering its growth profile. UBS sees a “catalyst-rich” 2026 for the company, with the potential of driving “significant stock upside on upcoming de-risking events.”

It added that Royalty Pharma Plc (NASDAQ:RPRX) has an attractive growth profile on both an absolute and relative basis compared to several large-cap pharma names experiencing material loss of exclusivities.

In addition to UBS, Citi also lifted the price target on Royalty Pharma Plc (NASDAQ:RPRX) to $50 from $48 on January 27, maintaining a Buy rating and adjusting price targets in the biopharma group as part of a fiscal Q4 preview. According to the firm, factors such as “beatable” estimates and reduced policy risk should create a favorable setup for the group in 2026.

Royalty Pharma Plc (NASDAQ:RPRX) funds innovation in the biopharmaceutical industry and buys biopharmaceutical royalties. It collaborates with innovators from research hospitals, non-profits, and academic institutions through small and mid-cap biotech companies to global pharma companies. The company funds innovation in the industry both directly, by partnering with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly, by acquiring existing royalties from the original innovators.

Page 4 of 11